ATC code J06

ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1][2][3] Subgroup J06 is part of the anatomical group J Antiinfectives for systemic use.^[4]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J06A Immune sera

J06AA Immune sera

J06AA01 Diphtheria antitoxin

J06AA02 Tetanus antitoxin

J06AA03 Snake venom antiserum

J06AA04 Botulinum antitoxin

J06AA05 Gas-gangrene sera

J06AA06 Rabies serum

J06B Immunoglobulins

J06BA Immunoglobulins, normal human

J06BA01 Immunoglobulins, normal human, for extravascular administration

J06BA02 Immunoglobulins, normal human, for intravascular administration

J06BB Specific immunoglobulins

J06BB01 Anti-D (rh) immunoglobulin

J06BB02 Tetanus immunoglobulin

J06BB03 Varicella/zoster immunoglobulin

J06BB04 Hepatitis B immunoglobulin

J06BB05 Rabies immunoglobulin

J06BB06 Rubella immunoglobulin

J06BB07 Vaccinia immunoglobulin

J06BB08 Staphylococcus immunoglobulin

J06BB09 Cytomegalovirus immunoglobulin

J06BB10 Diphtheria immunoglobulin

J06BB11 Hepatitis A immunoglobulin

J06BB12 Encephalitis, tick-borne immunoglobulin

J06BB13 Pertussis immunoglobulin

J06BB14 Morbilli immunoglobulin

J06BB15 Parotitis immunoglobulin

J06BB19 Anthrax immunoglobulin

J06BB30 Combinations

J06BC Antibacterial monoclonal antibodies

J06BC01 Nebacumab

J06BC02 Raxibacumab

J06BC03 Bezlotoxumab

J06BC04 Obiltoxaximab

J06BD Antiviral monoclonal antibodies

J06BD01 Palivizumab

J06BD02 Motavizumab

J06BD03 Tixagevimab and cilgavimab

J06BD04 Ansuvimab

J06BD05 Sotrovimab

J06BD06 Regdanvimab

J06BD07 Casirivimab and imdevimab

J06BD08 Nirsevimab

J06BD09 Sipavibart

See also

• Immune sera and immunoglobulins for veterinary use are in the ATCvet group QI.

References

1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. "ATC/DDD Index 2022: code J06". WHO Collaborating Centre for Drug Statistics Methodology.